Thus, we advocate the use of novel biomarkers such as cystatin-C, kidney injury molecule-1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL) to provide an accurate reflection of AKI. This evidence concerns the gene LCN2 and acute kidney injury.